Mucosal immunisation with papillomavirus virus-like particles elicits systemic and mucosal immunity in mice

Virology

Volumn 252, Issue 1, 1998, Pages 39-45

  Liu, Xiao Song ^a   Abdul Jabbar, Ibtissam ^a   Qi, Ying Mei ^a   Frazer, Ian H ^a   Zhou, Jian ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS NEUTRALIZATION; VIRUS PARTICLE; VIRUS RECOMBINANT;

ANIMALIA; BOVINAE; BOVINE PAPILLOMAVIRUS; BOVINE PAPILLOMAVIRUS TYPE 1; DNA VIRUSES; MIRIDAE; PAPILLOMAVIRUS;

EID: 0032488255     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9442     Document Type: Article

References (34)

1. Breitburd F., Kirnbauer R., Hubbert N. L., Nonnenmacher B., Trin-Dinh-Desmarquet C., Orth G., Schiller J. T., Lowy D. R. Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J. Virol. 69:1995;3959-3963.
2. Christensen N. D., Reed C. A., Cladel N. M., Han R., Kreider J. W. Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus. J. Virol. 70:1996;960-965.
3. Crowley-Nowick P. A., Bell M. C., Brockwell R., Edwards R. P., Chen S., Partridge E. E., Mestecky J. Rectal immunization for induction of specific antibody in the genital tract of women. J. Clin. Immunol. 17:1997;370-379.
4. Di Fabio S., Medaglini D., Rush C. M., Corrias F., Panzini G. L., Pace M., Verani P., Pozzi G., Titti F. Vaginal immunization of Cynomolgus monkeys withStreptococcus gordonii. Vaccine. 16:1998;485-492.
5. Evander M., Frazer I. H., Payne E., Qi Y. M., Hengst K., McMillan N. A. Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J. Virol. 71:1997;2449-2456.
6. Feltkamp M. C. W., Smits H. L., Vierboom M. P. M., Minnaar R. P., De Jongh B. M., Wouter Drijfhout J., Ter Schegget J., Melief C. J. M., Kast W. M. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur. J. Immunol. 23:1993;2242-2249.
7. Greenstone H. L., Nieland J. D., De Bruijn M. L., Kirnbauer R., Roden R. B., Lowy D. R., Kast W. M., Schiller J. T. Chemeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model. Proc. Natl. Acad. Sci. USA. 95:1998;1800-1805.
8. Hagensee M. E., Carter J. J., Wipf G. C., Galloway D. A. Immunization of mice with HPV vaccinia virus recombinants generates serum IgG, IgM, and mucosal IgA antibodies. Virology. 206:1995;174-182.
9. Hagensee M. E., Yaegashi N., Galloway D. A. Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J. Virol. 67:1993;315-322.
10. Hamilton-Easton A., Eichelberger M. Virus-specific antigen presentation by different subsets of cells from lung and mediastinal lymph node tissues of influenza virus-infected mice. J. Virol. 69:1995;6359-6366.
11. Hopkins S., Kraehenbuhl J. P., Schödel F., Potts A., Peterson D., De Grandi P., Nardelli-Haefliger D. A recombinantSalmonella typhimurium. Infect. Immun. 63:1995;3279-3286.
12. Husband A. J. Novel vaccination strategies for the control of mucosal infection. Vaccine. 11:1993;107-112.
13. Kirnbauer R., Booy F., Cheng N., Lowy D. R., Schiller J. T. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc. Natl. Acad. Sci. USA. 89:1992;12180-12184.
14. Kulski, J. K. Sadleir, J. W. Kelsall, S. R. Cicchini, M. S. Shellam, G. R. Peng, S. W. Qi, Y. M. Galloway, D. A. Zhou, J. Frazer, I. H. Type specific and genotype cross reactive B epitopes of the L1 protein of HPV16 defined by a panel of monoclonal antibodies, Virology.
15. Londono L. P., Chatfield S., Tindle R. W., Herd K., Gao X. M., Frazer I., Dougan G. Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigen. Vaccine. 14:1996;545-552.
16. Lowe R. S., Brown D. R., Bryan J. T., Cook J. C., George H. A., Hofmann K. J., Hurni W. M., Joyce J. G., Lehman E. D., Markus H. Z., Neeper M. P., Schultz L. D., Shaw A. R., Jansen K. U. Human papillomavirus type II (HPV-11) neutralizing antibodies in the serum and genital mucosal secretions of African green monkeys immunized with HPV-11 virus-like particles expressed in yeast. J. Infect. Dis. 176:1997;1141-1145.
17. McDermott M. R., Graham F. L., Hanke T., Johnson D. C. Protection of mice against lethal challenge with herpes simplex virus by vaccination with an adenovirus vector expressing HSV glycoprotein B. Virology. 169:1989;244-247.
18. Mestecky J., Kutteh W. H., Jackson S. Mucosal immunity in the female genital tract: Relevance to vaccination efforts against the human immunodeficiency virus. AIDS Res. Hum. Retroviruses. 10:1994;S11-S20.
19. Müller M., Zhou J. A., Reed T. D., Rittmüller C., Burger A., Gabelsberger J., Braspenning J., Gissmann L. Chimeric papillomavirus-like particles. Virology. 234:1997;93-111.
20. Nardelli-Haefliger D., Roden R. B., Benyacoub J., Sahli R., Kraehenbuhl J. P., Schiller J. T., Lachat P., Potts A., De Grandi P. Human papillomavirus type 16 virus-like particles expressed in attenuatedSalmonella typhimurium. Infect. Immun. 65:1997;3328-3336.
21. Paintsil J., Müller M., Picken M., Gissmann L., Zhou J. Carboxyl terminus of bovine papillomavirus type-1 L1 protein is not required for capsid formation. Virology. 223:1996;238-244.
22. Park D. S., Selvey L. A., Kelsall S. R., Frazer I. H. Human papillomavirus type 16 E6, E7 and L1 and type 18 E7 proteins produced by recombinant baculoviruses. J. Virol. Methods. 45:1993;303-318.
23. Peng S. W., Frazer I. H., Fernando G. J., Zhou J. Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway. Virology. 240:1998;147-157.
24. 6. J. Exp. Med. 186:1997;1725-1735.
25. Roche J. K., Crum C. P. Local immunity and the uterine cervix: Implications for cancer-associated viruses. Cancer Immunol. Immunother. 33:1991;203-209.
26. Roden R. B. S., Hubbert N. L., Kirnbauer R., Breitburd F., Lowy D. R., Schiller J. T. Papillomavirus L1 capsids agglutinate mouse erythrocytes through a proteinaceous receptor. J. Virol. 69:1995;5147-5151.
27. Roden R. B. S., Weissinger E. M., Henderson D. W., Booy F., Kirnbauer R., Mushinski J. F., Lowy D. R., Schiller J. T. Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins. J. Virol. 68:1994;7570-7574.
28. Schiller J., Lowy D. R. Papillomavirus-like particles and HPV vaccine development. Semin. Cancer Biol. 7:1996;373-382.
29. Suzich J. A., Ghim S. J., Palmer-Hill F. J., White W. I., Tamura J. K., Bell J. A., Newsome J. A., Jenson A. B., Schlegel R. Systemic immunzation with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc. Natl. Acad. Sci. USA. 92:1995;11553-11557.
30. Tindle R. W., Croft S., Herd K., Malcolm K., Geczy A. F., Stewart T., Fernando G. J. P. A vaccine conjugate of "ISCAR" immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomavirus type 16 elicits specific Th1-and Th2-type responses in immunized mice in the absence of oil-based adjuvants. Clin. Exp. Immunol. 101:1995;265-271.
31. Tindle R. W., Fernando G. J., Sterling J. C., Frazer I. H. A "public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes. Proc. Natl. Acad. Sci. USA. 88:1991;5887-5891.
32. Uehling D. T., Hopkins W. J., Balish E., Xing Y. N., Heisey D. M. Vaginal mucosal immunization for recurrent urinary tract infection: Phase II clinical trial. J. Urol. 157:1997;2049-2052.
33. VanCott T. C., Kaminski R. W., Mascola J. R., Kalyanraman V. S., Wassef N. M., Alving C. R., Ulrich J. T., Lowell G. H., Birx D. L. HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160. J. Immunol. 160:1998;2000-2012.
34. Zhou J., Sun X. Y., Stenzel D. J., Frazer I. H. Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology. 185:1991;251-257.